Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.

Additional Metadata
Persistent URL dx.doi.org/10.1016/j.ahj.2019.02.016, hdl.handle.net/1765/121002
Journal American Heart Journal
Citation
Vroegindewey, M.M, van den Berg, V.J, Bouwens, E. (Elke), Akkerhuis, K.M, Oemrawsingh, R.M, Asselbergs, F.W, … Boersma, H. (2019). Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission. American Heart Journal, 216, 143–146. doi:10.1016/j.ahj.2019.02.016